Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: JAMA Neurol. 2014 Oct;71(10):1255–1265. doi: 10.1001/jamaneurol.2014.1584

Figure 2. Flow diagram of study visits and procedures.

Figure 2

Each subject participated in 3 visits: Screening/baseline (initiation of triheptanoin supplementation), 3 month follow-up (discontinuation of triheptanoin supplementation), and 6 month follow up (study exit).